CLOSTRIDIUM HISTOLYTICUM ENZYM

European patent · EP2802652 · In force

Register entry

Publication number
EP2802652
Application number
EP13736040
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 10, 2013
Published
Nov 19, 2014
Granted
Jun 5, 2019
Protection ends at the latest
Jan 9, 2033
Next annual fee due
Jan 31, 2027
IPC classes
C12N 9/52 (2006.01)
Priority
US 201261585909 P 12.01.2012
PCT application
PCT/US2013/020940 10.01.2013
PCT publication
WO2013/106510 18.07.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Jun 5, 2019

    Granted

    Published in Swissreg on 05.06.2019

Parties

Holder

Endo Global Ventures

22 Victoria Street, Canon's Court, Hamilton HM12, BM

Inventor

HERBER, Wayne, K.

Coopersburg, PA 18036-9306, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.